NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE
Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO
Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Novo Nordisk A/s NVO
Why Novo Nordisk Topped the Market Today
Hardly for the first time in recent weeks and months, Novo Nordisk (NYSE: NVO) had a good trading session on the stock market Monday. The company's shares enjoyed a more than 2% boost on the day, comparing favorably to the 0.9% rise of the S&P 500 inde
Announcement as on 22 April 2024
Novo Nordisk to buy Cardior Pharma for up to billion
Novo Nordisk A/S bought Cardior Pharmaceuticals for billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies aim to improve heart function, aligning with Novo's focus on diabetes and obesity history.
Announcement as on 26 March 2024
Novo Nordisk owner joins the race for Healthium Medtech
Novo Holdings is the latest challenger in a hotly contested bidding process for Healthium, 99.8% owned by Apax Partners. Buyout funds KKR, Hillhouse, EQT, Blackstone and TA Associates among others have already been shortlisted after the initial rounds, ET
Announcement as on 22 March 2024
Why Novo Nordisk Stock Was a Winner Today
One of the healthcare stocks of the moment, Novo Nordisk (NYSE: NVO), had a good Tuesday on the market. Investors pushed its price 3% higher, more than double the percentage rate increase of the S&P 500 index, on the back of a positive move by an analy
Announcement as on 13 March 2024
Novo Nordisk's (NVO) Wegovy Gets FDA Nod to Reduce Heart Risk
Novo Nordisk NVO announced that the FDA has approved its supplemental new drug application (sNDA) seeking label expansion for Wegovy (semaglutide 2.4 mg) to reduce the risks of major adverse cardiovascular events (MACE), including
Announcement as on 11 March 2024
Announcements by Novo Nordisk A/s first page | Next page | Prev page |
NVO Novo Nordisk A/s current price & indicator signals
Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 20 Fri Nov 2026 | 37.82 | 37.75 to 39.12 | -2.75% | 1.12 times |
| 19 Thu Nov 2026 | 38.89 | 38.61 to 39.82 | -1.42% | 0.78 times |
| 18 Wed Nov 2026 | 39.45 | 39.32 to 40.57 | -3.1% | 1.22 times |
| 17 Tue Nov 2026 | 40.71 | 40.23 to 41.66 | -2.14% | 1.08 times |
| 16 Mon Nov 2026 | 41.60 | 41.44 to 42.30 | -0.07% | 1.2 times |
| 13 Fri Nov 2026 | 41.63 | 40.64 to 41.80 | 2.41% | 1 times |
| 12 Thu Nov 2026 | 40.65 | 40.08 to 41.01 | -1.07% | 1.35 times |
| 11 Wed Nov 2026 | 41.09 | 40.10 to 41.20 | 0.96% | 1 times |
| 10 Tue Nov 2026 | 40.70 | 40.38 to 40.81 | -1.64% | 0.56 times |
| 09 Mon Nov 2026 | 41.38 | 40.55 to 41.63 | 2.65% | 1.01 times |
| 06 Fri Nov 2026 | 40.31 | 39.53 to 40.55 | 0.02% | 0.79 times |
| 05 Thu Nov 2026 | 40.30 | 39.99 to 41.17 | -4.46% | 1.59 times |
Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


